Inhibitory effect of dsRNA TLR3 agonist in a rat hepatocellular carcinoma model

Molecular Medicine Reports

Volumn 8, Issue 4, 2013, Pages 1037-1042

  Xu, Yu Yin ^a   Chen, Li ^a   Zhou, Ia Ming ^a   Wu, Yuan Yuan ^a   Zhu, Yuan Yuan ^b  

^a NANTONG UNIVERSITY   (China)

^b Biomics Biotechnologies   (China)

Author keywords

Apoptosis; Double stranded RNA; Hepatocellular carcinoma; Toll like receptor 3

Indexed keywords

ANTINEOPLASTIC AGENT; BM 06; CASPASE 3; CASPASE 8; CYCLINE; DOUBLE STRANDED RNA; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LAMININ; MESSENGER RNA; N (2 FLUORENYL)ACETAMIDE; PHOSPHATE BUFFERED SALINE; POLYINOSINIC POLYCYTIDYLIC ACID; PROTEIN BCL 2; SURVIVIN; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR AGONIST; UNCLASSIFIED DRUG; VASCULOTROPIN; BM-06; CASP8 PROTEIN, RAT; TLR3 PROTEIN, RAT; VASCULAR ENDOTHELIAL GROWTH FACTOR A, RAT; VASCULOTROPIN A;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFICACY; GENE EXPRESSION REGULATION; HISTOPATHOLOGY; IN VIVO STUDY; LIVER CELL CARCINOMA; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; AGONISTS; ANIMAL; DRUG EFFECTS; DRUG SCREENING; GENE EXPRESSION; GENETICS; LIVER; LIVER NEOPLASMS, EXPERIMENTAL; METABOLISM; PATHOLOGY; SPRAGUE DAWLEY RAT; TUMOR VOLUME;

RATTUS;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CASPASE 8; CELL PROLIFERATION; DRUG SCREENING ASSAYS, ANTITUMOR; GENE EXPRESSION; INTERFERON-GAMMA; LIVER; LIVER NEOPLASMS, EXPERIMENTAL; MALE; NF-KAPPA B; RATS; RATS, SPRAGUE-DAWLEY; RNA, DOUBLE-STRANDED; RNA, MESSENGER; TOLL-LIKE RECEPTOR 3; TUMOR BURDEN; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84883426762     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2013.1646     Document Type: Article

References (18)

1. Yang JD and Roberts LR: Hepatocellular carcinoma: A global view. Nat Rev Gastroenterol Hepatol 7: 448-458, 2010.
2. Nerenstone SR, Ihde DC and Friedman MA: Clinical trials in primary hepatocellular carcinoma: current status and future directions. Cancer Treat Rev 15: 1-31, 1988.
3. Mathurin P, Rixe O, Carbonell N, Bernard B, Cluzel P, Bellin MF, Khayat D, Opolon P and Poynard T: Review article: Overview of medical treatments in unresectable hepatocellular carcinoma - an impossible meta-analysis? (Review) Aliment Pharmacol Ther 12: 111-126, 1998.
4. Llovet JM, Burroughs A and Bruix J: Hepatocellular carcinoma. Lancet 362: 1907-1917, 2003.
5. Kawano Y, Sasaki A, Kai S, Endo Y, Iwaki K, Uchida H, Shibata K, Ohta M and Kitano S: Prognosis of patients with intrahepatic recurrence after hepatic resection for hepatocellular carcinoma: a retrospective study. Eur J Surg Oncol 35: 174-179, 2009.
6. Yamamoto M, Sato S, Hemmi H, Hoshino K, Kaisho T, Sanjo H, Takeuchi O, Sugiyama M, Okabe M, Takeda K and Akira S: Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science 301: 640-643, 2003.
7. Alexopoulou L, Holt AC, Medzhitov R and Flavell RA: Recognition of double-stranded RNA and activation of NFkappaB by Toll-like receptor 3: Nature 413: 732-738, 2001.
8. Heylbroeck C, Balachandran S, Servant MJ, DeLuca C, Barber GN, Lin R and Hiscott J: The IRF-3 transcription factor mediates Sendai virus-induced apoptosis. J Virol 74: 3781-3792, 2000.
9. Salaun B, Coste I, Rissoan MC, Lebecque SJ and Renno T: TLR3 can directly trigger apoptosis in human cancer cells. J Immunol 176: 4894-4901, 2006.
10. Salaun B, Lebecque S, Matikainen S, Rimoldi D and Romero P: Toll-like receptor 3 expressed by melanoma cells as a target for therapy? Clin Cancer Res 13: 4565-4574, 2007.
11. Qun E, Li Chen, Guo Hua Jin, et al: portfolio tool of paraffin tissue microarray[Z]. CN201402229: Nantong university, 2010.
12. Qun E, Li Chen, Qiu Kai E: preparation methods of paraffin tissue microarray[Z]. CN101319971: Nantong university, 2008.
13. Khvalevsky E, Rivkin L, Rachmilewitz J, Galun E and Giladi H: TLR3 signaling in a hepatoma cell line is skewed towards apoptosis. J Cell Biochem 100: 1301-1312, 2007.
14. Chua CW and Choo SP: Targeted therapy in hepatocellular carcinoma. Int J Hepatol 2011: 348297, 2011.
15. Bergé M, Bonnin P, Sulpice E, Vilar J, Allanic D, Silvestre JS, Lévy BI, Tucker GC, Tobelem G and Merkulova-Rainon T: Small interfering RNAs induce target-independent inhibition of tumor growth and vasculature remodeling in a mouse model of hepatocellular carcinoma. Am J Pathol 177: 3192-3201, 2010.
16. Zorde-Khvalevsky E, Abramovitch R, Barash H, Spivak-Pohis I, Rivkin L, Rachmilewitz J, Galun E and Giladi H: Toll-like receptor 3 signaling attenuates liver regeneration. Hepatology 50: 198-206, 2009.
17. Ferreon JC, Ferreon AC, Li K and Lemon SM: Molecular determinants of TRIF proteolysis mediated by the hepatitis C virus NS3/4A protease: J Biol Chem 280: 20483-20492, 2005.
18. Kleinman ME, Yamada K, Takeda A, Chandrasekaran V, Nozaki M, Baffi JZ, Albuquerque RJ, Yamasaki S, Itaya M, Pan Y, et al: Sequence- and target-independent angiogenesis suppression by siRNA via TLR3. Nature 452: 591-597, 2008.